Carl Zeiss Meditec AG (CZMWF)
55.09
0.00 (0.00%)
USD |
OTCM |
Dec 13, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.822B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -43.45% |
| Valuation | |
| PE Ratio | 25.21 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.182 |
| Price to Book Value | 2.115 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 1.195 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 71.62% |
Profile
| Carl Zeiss Meditec is a Jena, Germany-based manufacturer of ophthalmic devices, such as intraocular lenses, diagnostic equipment, and refractive laser systems, along with optical equipment for microsurgical applications such as neurosurgery. The company now reports in two primary segments, ophthalmic devices (76% of fiscal 2021 revenue) and microsurgery (24%). From a geographic perspective, the firm has a balanced mix of global sales, with 65% derived from Europe, the Middle East, and Africa, 29% from the Americas, and 6% from Asia-Pacific. |
| URL | https://www.zeiss.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Mid Cap/Growth |
| Next Earnings Release | Feb. 07, 2025 (est.) |
| Last Earnings Release | Dec. 11, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 22, 2024 |
Ratings
Profile
| Carl Zeiss Meditec is a Jena, Germany-based manufacturer of ophthalmic devices, such as intraocular lenses, diagnostic equipment, and refractive laser systems, along with optical equipment for microsurgical applications such as neurosurgery. The company now reports in two primary segments, ophthalmic devices (76% of fiscal 2021 revenue) and microsurgery (24%). From a geographic perspective, the firm has a balanced mix of global sales, with 65% derived from Europe, the Middle East, and Africa, 29% from the Americas, and 6% from Asia-Pacific. |
| URL | https://www.zeiss.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Mid Cap/Growth |
| Next Earnings Release | Feb. 07, 2025 (est.) |
| Last Earnings Release | Dec. 11, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 22, 2024 |